A detailed history of Citigroup Inc transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Citigroup Inc holds 65,642 shares of AVNS stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,642
Previous 59,195 10.89%
Holding current value
$1.09 Million
Previous $1.42 Million 26.51%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$15.58 - $23.61 $100,444 - $152,213
6,447 Added 10.89%
65,642 $1.05 Million
Q3 2024

Nov 12, 2024

BUY
$19.21 - $24.69 $429,670 - $552,241
22,367 Added 60.73%
59,195 $1.42 Million
Q2 2024

Aug 12, 2024

BUY
$17.85 - $20.42 $59,404 - $67,957
3,328 Added 9.93%
36,828 $733,000
Q1 2024

May 10, 2024

BUY
$17.97 - $22.68 $87,999 - $111,063
4,897 Added 17.12%
33,500 $666,000
Q4 2023

Feb 09, 2024

BUY
$17.64 - $22.99 $189,383 - $246,820
10,736 Added 60.09%
28,603 $641,000
Q3 2023

Nov 09, 2023

SELL
$19.93 - $26.31 $405,774 - $535,671
-20,360 Reduced 53.26%
17,867 $361,000
Q2 2023

Aug 10, 2023

BUY
$22.53 - $30.98 $277,299 - $381,301
12,308 Added 47.49%
38,227 $977,000
Q1 2023

May 11, 2023

SELL
$26.92 - $31.75 $160,523 - $189,325
-5,963 Reduced 18.7%
25,919 $770,000
Q4 2022

Feb 09, 2023

BUY
$19.88 - $27.37 $187,050 - $257,524
9,409 Added 41.87%
31,882 $862,000
Q3 2022

Nov 10, 2022

BUY
$21.56 - $29.59 $19,727 - $27,074
915 Added 4.24%
22,473 $489,000
Q2 2022

Aug 10, 2022

SELL
$24.87 - $34.68 $502,597 - $700,848
-20,209 Reduced 48.39%
21,558 $589,000
Q1 2022

May 12, 2022

BUY
$28.87 - $35.77 $132,022 - $163,576
4,573 Added 12.29%
41,767 $1.4 Million
Q4 2021

Feb 10, 2022

BUY
$29.25 - $36.02 $325,611 - $400,974
11,132 Added 42.71%
37,194 $1.29 Million
Q3 2021

Nov 10, 2021

BUY
$31.2 - $38.5 $813,134 - $1 Million
26,062 New
26,062 $813,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $770M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.